In our current breast cancer studies, we further confirmed that CD147 expression was associated with the ability to resist anoikis, with AR MDA-MB-231 cells having significantly higher CD147 expression compared to the anoikis sensitive T-47D and MCF7 cells (Supplementary Figures S2E,F, S3Aleft). This evidence concerns the gene BSG and breast carcinoma.